HONOLULU – The Hawai‘i Department of Health is reporting that cases of Respiratory Syncytial Virus (RSV) and influenza are increasing in Hawaiʻi, in line with trends observed across the country.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but children under the age of five, and in particular infants, are at highest risk for severe RSV infections. Older adults, especially those with underlying medical conditions, can also experience severe illness.
“Many respiratory viruses are circulating in our community, including RSV, COVID-19, and influenza,” said State Epidemiologist Dr. Sarah Kemble. “We urge all eligible individuals to get vaccinated against COVID-19 and influenza and take simple preventive measures that stop the spread of respiratory viruses.”
In 2020 and 2021, RSV and influenza cases declined sharply, as COVID-19 mitigation measures also prevented the spread of these viruses. Since these measures were relaxed, RSV cases have been rising.
RSV cases typically increase in the fall and peak in winter. This year’s total testing volume (positive and negative tests) and percent positivity are both increasing quickly early in the season. Out of an average of 1,858 RSV tests performed per week statewide in recent weeks, 23% were positive. This indicates there is a high level of both detected and undetected RSV infection in the community.
Influenza activity in Hawaiʻi remains low but is increasing. Out of 3,886 specimens tested for influenza statewide in the week of October 16–22, 5.8% were positive. During a similar timeframe, statewide COVID-19 test positivity was 6.4% out of 14,927 tests performed. COVID-19 test positivity declined to 5.3% in the current week.
People concerned about the flu or other respiratory viruses can take simple preventive measures like staying away from others who are sick, staying home if they’re sick, washing their hands, covering their cough, and wearing a mask.
DOH recommends flu shots for individuals six months and older. COVID-19 vaccinations are recommended for everyone six months and older and COVID-19 bivalent boosters are recommended for everyone age five and older.
COVID-19 vaccinations and bivalent boosters can be scheduled through providers found at HawaiiCOVID19.com/vaccine. Many providers and pharmacies allow the scheduling of flu shots when scheduling your COVID-19 vaccines or boosters.
# # #
Denby Fawcett: Why So Few People Are Getting The New Covid Shot
Experts are worried about the lack of interest as people are still suffering from the virus and long Covid. By Denby Fawcett Original article on Civil Beat, November 7, 2023 I keep a card in my [...]
Federal Public Health Emergency (PHE) for COVID-19 ends on May 11, 2023
HONOLULU, HI –The federal Public Health Emergency (PHE) for COVID-19, declared under Section 319 of the Public Health Service Act, will expire at the end of the day on May 11, 2023. As the PHE [...]
Seniors now eligible for additional COVID-19 bivalent booster dose, COVID vaccine recommendations simplified
HONOLULU, HI – The Hawai‘i Department of Health (DOH) supports the latest recommendations announced yesterday by the Centers for Disease Control and Prevention (CDC), allowing an additional dose of the bivalent booster against the virus [...]
Hawai‘i COVID-19 hospitalizations on the rise
HONOLULU, HI – The Hawai‘i Department of Health (DOH) reports a rise in the rate of COVID-19 hospitalizations. The number of total positive COVID-19 hospitalizations has increased over the past week (3/26 – 4/4) from [...]
Wastewater Samples Show Higher COVID Concentrations & New Subvariant
The Hawai‘i State Department of Health’s most recent Wastewater Surveillance Report documents two significant developments about COVID-19 in Hawai‛i. Higher concentrations of the virus that causes COVID-19 The arrival of the XBB.1.5 subvariant Higher concentrations [...]
Bivalent boosters for keiki as young as 6 months
Updated COVID-19 bivalent boosters are now available in all counties for keiki as young as six months of age. The U.S. Food and Drug Administration (FDA) amended the emergency use authorization for the bivalent boosters [...]